Donald Huffman

Donald Huffman

Plus aucun poste en cours
79 ans
Health Technology
Consumer Services
Finance

Profil

Donald D.
Huffman
served as Chief Financial Officer at Celtrix Pharmaceuticals, Inc. from 1981 to 2000.
Held Chief Financial Officer roles at Sanderling Management CO LLC (2004-2006), Guava Technologies, Inc. (2006-2008), Asante Solutions, Inc. (2008-2010), and WaferGen Bio-systems, Inc. (2010-2012).
Occupied Chief Executive Officer & Chief Financial Officer positions at WaferGen Bio-systems, Inc. from 2010 to 2012.
Served as Director at Aerami Therapeutics, Inc. (2013-2014), SteadyMed Therapeutics, Inc. (2015-2018), and Aerami Therapeutics Holdings, Inc. Also held External Director role at SteadyMed Ltd. (2015-2018).
Chief Executive Officer & Director at Amarantus Bioscience Holdings, Inc. from 2021 to 2025.
Held Chief Financial Officer roles at Merck & Co., Inc., Essential Therapeutics, Inc., Philips Image Guided Therapy Corp., and Genteric, Inc. Education includes undergraduate degree from The Pennsylvania State University and MBA from State University of New York at Buffalo.

Anciens postes connus de Donald Huffman

SociétésPosteFin
AMARANTUS BIOSCIENCE HOLDINGS, INC. Directeur Général 01/10/2025
STEADYMED LTD Directeur/Membre du Conseil 30/08/2018
Directeur/Membre du Conseil 01/01/2018
WAFERGEN BIO-SYSTEMS, INC. Directeur Financier/CFO 26/03/2012
ASANTE SOLUTIONS INC Directeur Financier/CFO 01/09/2010
Voir l'expérience en détail de Donald Huffman

Formation de Donald Huffman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

32

Relations au 1er degré

16

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées16

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Donald Huffman